INTEGRA LIFESCIENCES HOLDINGS CORP (IART) › Operating Cash FlowINTEGRA LIFESCIENCES HOLDINGS CORP (IART) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2008: $72.59M2009: $143.24M2010: $105.57M2011: $104.33M2012: $59.10M2013: $53.27M2014: $83.56M2015: $104.85M2016: $116.41M2017: $114.54M2018: $199.68M2019: $231.43M2020: $203.83M2021: $312.43M2022: $264.47M2023: $139.96M2024: $129.38M2025: $50.38M$50.38M2008Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$50.38M-61.1%2024$129.38M-7.6%2023$139.96M-47.1%2022$264.47M-15.4%2021$312.43M+53.3%2020$203.83M-11.9%2019$231.43M+15.9%2018$199.68M+74.3%2017$114.54M-1.6%2016$116.41M+11.0%2015$104.85M+25.5%2014$83.56M+56.9%2013$53.27M-9.9%2012$59.10M-43.4%2011$104.33M-1.2%2010$105.57M-26.3%2009$143.24M+97.3%2008$72.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share